BioProcess International reviews key biotech trends from the first half of 2026, including US onshoring, China's biologics ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

The work with Nvidia also focuses on the agentic guardrails required for the responsible and reliable deployment of AI in lab ...

In a joint letter to Treasurer Jim Chalmers, 17 industry organisations called for consultation on two RDTI changes announced ...

Background The ocean harbors an immense, largely untapped diversity of microorganisms—bacteria, fungi, yeasts, thraustochytrids, and microalgae—whose ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...

In an interview, synthetic biologist Peter Carr explains research on synthetic cells, their potential benefits and hazards, ...

What do Botox, rat poison, weight-loss drugs and a fictional murder investigation have in common? At the University of Nevada ...

It's customer lifetime value. And you can’t earn lifetime value in June alone; you earn it in the other 11 months of the year ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...